NHS Logo
As One Logo

Antipsychotic depots/LAIs

Prescribing and administration by HPFT services unless prior agreement and clinical management plan in place for prescribing and administration to be transferred to primary care.

Antipsychotic depots /Long acting injections (LAIs) Preparations Comments
See guidance on IM Administration of oil-based Depot and other Long-Acting Antipsychotic Injections
Aripiprazole  400mg injection

See Appendix 4 Guidance on Choice and Selection of Antipsychotics for the Management of Psychosis and Schizophrenia in Adults

Flupentixol decanoate 20mg/ml, 40mg/2ml, 50mg/0.5ml, 100mg/1ml, 200mg/ml injection  
Haloperidol decanoate 50mg/ml, 100mg/ml injection Baseline ECG is recommended. See DTC recommendation on haloperidol and ECG monitoring
Olanzapine pamoate 210mg, 300mg, 405mg vials for reconstitution with provided solvent

Prior approval required. See Appendix 5 of Choice and Selection of Antipsychotics for Management of Psychosis & Schizophrenia in Adults for prescribing and guidance and request form. 

Paliperidone palmitate 1-monthly 50mg, 75mg, 100mg, 150mg pre-filled syringes

Tablets NOT APPROVED. 

See Appendix 2 Guidance on Choice and Selection of Antipsychotics for the Management of Psychosis and Schizophrenia in Adults

Paliperidone palmitate 3-monthly (Trevicta®)  175mg, 263mg, 350mg, 525mg pre-filled syringes

Named patient request ONLY

See Appendix 3 Guidance on Choice and Selection of Antipsychotics for the Management of Psychosis and Schizophrenia in Adults

Zuclopenthixol decanoate (Clopixol®) 200mg/ml, 500mg/ml injection  

 

Back to Antipsychotic drugs

 

Back to Contents Page

Back to BNF Chapter 4

 

 

 

Contact Us